The Liberty Braves Group (BATRA) At $22.32 Forms Bottom; ABATTIS BIOCEUTICALS ORDINARY SHAR (ATTBF) Shorts Decreased By 97.45%

Abattis Bioceuticals Corp. (OTCMKTS:ATTBF) Logo

The Liberty Braves Group (BATRA) formed multiple bottom with $20.53 target or 8.00% below today’s $22.32 share price. The Liberty Braves Group (BATRA) has $1.15B valuation. The stock increased 0.68% or $0.15 during the last trading session, reaching $22.32. About 351,038 shares traded or 430.81% up from the average. The Liberty Braves Group (NASDAQ:BATRA) has risen 2.98% since May 6, 2017 and is uptrending. It has underperformed by 8.57% the S&P500.

ABATTIS BIOCEUTICALS CORP ORDINARY SHAR (OTCMKTS:ATTBF) had a decrease of 97.45% in short interest. ATTBF’s SI was 4,500 shares in May as released by FINRA. Its down 97.45% from 176,500 shares previously. The stock decreased 3.09% or $0.005 during the last trading session, reaching $0.166. About 742,761 shares traded. Abattis Bioceuticals Corp. (OTCMKTS:ATTBF) has 0.00% since May 6, 2017 and is . It has underperformed by 11.55% the S&P500.

Abattis Bioceuticals Corp., a biotechnology company, develops, licenses, and markets health products, medicines, extractions, and ingredients for the biologics, nutraceutical, bioceutical, and cosmetic markets in Canada. The company has market cap of $61.30 million. It is also involved in the possession of cannabis and related active ingredients, as well as the production of extracts; and bioceutical marketing services in the area of health products. It currently has negative earnings. The firm was formerly known as Abattis Biologix Corporation and changed its name to Abattis Bioceuticals Corp. in September 2012.